Clinical Trial Update: A Study to Compare the Response to Treatment With Abatacept vs Adalimumab, on Background Methotrexate, in Adults With Early, Seropositive, and Shared Epitope-positive Rheumatoid Arthritis and an Inadequate Response to Methotrexate [Phase 3]

View source ↗

Summary

Phase 3 trial update reporting results from a head-to-head comparison of abatacept versus adalimumab, each added to background methotrexate, in adults with earl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Humira (adalimumab)
• ORENCIA (ABATACEPT)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Rheumatoid Arthritis | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2024-10-15